Lifemd Inc (LFMD)
5.80 x 1 5.92 x 1
Post-market by (Cboe BZX)
5.94 +0.28 (+4.95%) 03/14/25 [NASDAQ]
5.80 x 1 5.92 x 1
Post-market 5.71 -0.23 (-3.87%) 19:43 ET
for Fri, Mar 14th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
Sales | 64,255 | 53,393 | 50,662 | 44,144 | 44,860 |
Cost of Goods | 9,430 | 5,014 | 5,025 | 4,600 | 5,356 |
Gross Profit | 54,825 | 48,380 | 45,637 | 39,544 | 39,504 |
Operating Expenses | 54,236 | 53,079 | 51,967 | 46,316 | 42,031 |
Operating Income | 1,018 | -4,686 | -6,306 | -6,171 | -2,172 |
Interest Expense | 614 | 559 | 532 | 478 | 623 |
Pre-tax Income | 404 | -5,245 | -6,837 | -6,649 | -2,794 |
Income Tax | 170 | 233 | N/A | N/A | N/A |
Net Income Continuous | 235 | -5,477 | -6,837 | -6,649 | -3,222 |
Minority Interests | 341 | -346 | 39 | 119 | 510 |
Net Income | $-106 | $-5,132 | $-6,876 | $-6,768 | $-3,732 |
EPS Basic Total Ops | -0.01 | -0.14 | -0.19 | -0.19 | -0.12 |
EPS Basic Continuous Ops | 0.01 | -0.13 | -0.17 | -0.17 | -0.08 |
EPS Diluted Total Ops | -0.01 | -0.14 | -0.19 | -0.19 | -0.12 |
EPS Diluted Continuous Ops | 0.01 | -0.13 | -0.17 | -0.17 | -0.08 |
EPS Diluted Before Non-Recurring Items | N/A | -0.14 | -0.19 | -0.19 | -0.12 |
EBITDA(a) | $3,666 | $-2,029 | $-3,917 | $-3,972 | $-130 |